The pharma industry is moving faster than ever. Medicines are manufactured, rigorously tested, and dispatched through a carefully curated process that’s followed diligently. But what if there’s a loophole in one of the areas where a pharma company is behind?

A small deviation or non-conformance could affect product quality greatly. CAPA in pharma provides a systematic structure to address these underlying issues at their root. CAPA in pharma industry- what’s that? What stages are involved? And how does it contribute to a better quality management system? Let’s find out.

What Is CAPA in Pharma?

CAPA stands for corrective and preventive action. It is a formal quality management process that is used to investigate and address problems that occur in the pharmaceutical industry.

Corrective action involves identifying and eliminating the root cause of an issue. Preventive action is a measure taken to prevent any existing or potential problems that may come in the future.

For example, if a machine malfunctions, corrective actions would identify what caused the machine to malfunction, identify the causes, and provide a solution. In contrast, preventive actions would eliminate any such recurrence in the future. So, what is CAPA in pharma? CAPA definition in pharma refers to identifying, solving, and preventing any issue.

Why Is CAPA Important in the Pharmaceutical Industry?

Errors are not uncommon. It is important to be prepared to face them. Applying CAPA in pharma industry not only solves an issue at its occurrence but can also eradicate any chances of it happening again. Here are a few reasons why CAPA is important:

• Protects product quality by keeping the products and patients safe through effective CAPA in quality assurance
• Reduces recurring deviations by addressing the root cause
• Acts as a quality management system and improves functionality
• Addresses audit observations by resolving every preexisting issue
• Identifies and resolves any deviation and ensures internal processes are run smoothly

An effective CAPA framework should operate within a broader GxP-compliant quality management system .

Corrective Action vs Preventive Action in Pharma

A CAPA analysis helps in identifying the primary cause of an issue and prevents any persistent troubles. There are various types of CAPA in pharma, and understanding the basic differences will help. Here are the differences between corrective and preventive action:

One must understand that correction and corrective action are not the same. A correction is something that’s done to resolve an issue, whereas a corrective action is a much broader act, as it identifies the underlying root causes while providing a solution.

What Can Trigger a CAPA in Pharma?

There are many quality events or indications that could trigger a CAPA in pharma. There is nothing suspicious about it; it is quite common. Certain events include repeated deviations, complaints regarding the product, manufacturing shortcomings, and a few other events that revolve around the quality of the product or process.

To avoid unfavourable audit results, availing pharmaceutical audit services could help in identifying these gaps and nipping any issues in the bud. Pharma companies employ effective deviation management to determine the appropriate response. Non-conformance may also necessitate a corrective or preventive action.

A CAPA analysis evaluates a surfeit of factors through risk assessment to determine whether it would be needed or not.

7 Steps of CAPA for the Pharmaceutical Industry

CAPA is a systematized approach for investigating, addressing, and preventing any quality problems. A well-laid-out CAPA process in pharma involves various steps without leaving any stones unturned. Here are the 7 steps of CAPA for the pharmaceutical industry:

1. Identify and Document the Problem

The first step of the CAPA process in pharma is to spot the cause and document it. They will clearly document every detail, such as what happened, when it took place, which product got flagged, which process failed, or which system malfunctioned. They start by recording objective evidence, which may also include non-conformances, deviations, complaints, and quality issues.

2. Perform Risk Assessment

Once the problem is identified and documented, CAPA suggests performing a risk assessment. A risk assessment analyzes the severity, probability, detectability, patient safety, and regulatory impact. Once this is done, it helps in determining the relevant solution based on the investigation report.

3. Conduct Root Cause Analysis

Root cause analysis is a critical stage. An issue can be rectified, but a corrective action hinges on preventing it from happening again. This stage of the CAPA analysis may involve investigation techniques such as failure mode and effects analysis, 5 whys, fishbone, and trend analysis.

4. Define Corrective and Preventive Actions

Once the root cause is spotted and understood, the appropriate corrective and preventive action must be defined properly. Corrective action will help in solving the issue at hand at that time, whereas a preventive action would eliminate any future recurrence. An action owner, along with completed date and expected outcome, will be assigned.

5. Implement the CAPA Plan

In this stage of the CAPA process in pharma, approved action plans are executed along with proper documentation. There is a high chance that the SOPs will be asked to be modified, along with employee training and computer-system updates. In such cases where those are prescribed, availing pharmaceutical training programs and software validation services for your team can support relevant implementation activities.

6. Verify CAPA Effectiveness

CAPA doesn’t stop at implementation. A monitoring period along with a targeted outcome is given for effectiveness verification. CAPA guidelines in pharma recommend conducting this time-bound proof to testify that the reported issue was actually sorted and stopped from happening again in the future.

7. Review, Approve and Close the CAPA

CAPA in quality assurance must validate that the root cause was identified, the prescribed actions were taken, and all the evidence was also documented while demonstrating CAPA effectiveness. Once the requirements are met, the CAPA is approved for closure. Completed CAPA’s are periodically reviewed to study the trends within the quality management system.

Example of CAPA in Pharma

Let’s take an example of a pharmaceutical company repeatedly printing incorrect expiry dates on their medicines. Here’s how CAPA analysis fixes it:

• Problem: Printing incorrect expiry dates on product labels.
• Investigation: As part of the CAPA analysis, the company reviews batch records, printing pre-settings, operator behaviour, and approval records of the medicines before dispatch.
• Root Cause: The label template wasn’t properly updated after product change.
• Corrective action: Replace the existing label with a new approved template.
• Preventive action: Induct another person into the final verification by replacing the existing one for manual inspection before dispatch.
• Effectiveness verification: Review subsequent batches to confirm that no incorrect expiry dates are detected.

This deviation management approach showcases how corrective and preventive action can solve an issue and prevent it from happening again.

CAPA Guidelines and Best Practices in Pharma

CAPA guidelines in pharma must incorporate a risk-based approach and proper quality procedures within the quality management system. An effective CAPA program includes:

• Stringent criteria for CAPA initiation and evidence-backed root cause analysis.
• Risk-based prioritization with properly defined responsibilities and deadlines.
• Measurable criteria for effectiveness verification before closure.
• Traceable documentation through a well-defined CAPA SOP in pharma.
• CAPA integration with deviation management and change control where needed.

Employee competency is evaluated during CAPA implementation, taking regular pharmaceutical training courses online helps in developing relevant knowledge and skills.

Role of Digital Systems in CAPA Management

Validated digital systems can streamline CAPA management by tracking the complete process. From the time of CAPA initiation and investigation to approvals until the final audit, it traces every movement. These systems improve visibility and transparency within the quality management system and help in maintaining regulatory compliance. Computer system validation in pharma is imperative when digital systems are used to manage regulated quality processes.

Conclusion

CAPA in pharma is indispensable. It does not just focus on tending to a thriving issue, but instead it analyzes what caused it and provides a solution, and from thereon it goes one step further by providing a solution which prevents it from happening again. By incorporating a streamlined process, more pharma companies can create more reliable quality systems. For expert guidance on GxP systems, pharmaceutical quality and compliance, connect with QIS .

Frequently Asked Questions About CAPA in Pharma

1. What is CAPA in pharma?

CAPA is a well-defined, structured process that solves and prevents issues in pharma.

2. What is the full form of CAPA in pharma?

CAPA full form in pharma is Corrective and Preventive Action.

3. What are the 7 steps of CAPA for the pharmaceutical industry?

The 7 steps of CAPA for the pharmaceutical industry are identification, risk assessment, root cause analysis, action planning, implementation, effectiveness verification, and closure.

4. What is an example of CAPA in pharma?

An example of CAPA in pharma is correcting a labelling error and introducing verification checks to prevent it from happening again.

5. Does every deviation require a CAPA?

No. Deviation management uses risk assessment to assess the severity and potential impact to determine if CAPA would be necessary.

6. How is CAPA effectiveness verified?

Effectiveness verification involves monitoring defined outcomes over a stipulated period to confirm whether it has recurred or not.